These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35749929)

  • 1. Molecular glues to stabilise protein-protein interactions.
    Soini L; Leysen S; Davis J; Ottmann C
    Curr Opin Chem Biol; 2022 Aug; 69():102169. PubMed ID: 35749929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Protein-Protein Interactions for the Development of Novel Therapeutics.
    Petta I; Lievens S; Libert C; Tavernier J; De Bosscher K
    Mol Ther; 2016 Apr; 24(4):707-18. PubMed ID: 26675501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of molecular glues of the SLP76/14-3-3 protein-protein interaction.
    Soini L; Redhead M; Westwood M; Leysen S; Davis J; Ottmann C
    RSC Med Chem; 2021 Sep; 12(9):1555-1564. PubMed ID: 34667951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
    Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
    Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
    Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
    Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.
    Harati S; Cooper LA; Moran JD; Giuste FO; Du Y; Ivanov AA; Johns MA; Khuri FR; Fu H; Moreno CS
    PLoS One; 2017; 12(1):e0170339. PubMed ID: 28118365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncellular screening for the discovery of protein-protein interaction modulators.
    Kieffer C; Jourdan JP; Jouanne M; Voisin-Chiret AS
    Drug Discov Today; 2020 Sep; 25(9):1592-1603. PubMed ID: 32682931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
    Shin WH; Christoffer CW; Kihara D
    Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting protein-protein interactions as an anticancer strategy.
    Ivanov AA; Khuri FR; Fu H
    Trends Pharmacol Sci; 2013 Jul; 34(7):393-400. PubMed ID: 23725674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-protein complexes as targets for drug discovery against infectious diseases.
    Akhter Y; Hussain R
    Adv Protein Chem Struct Biol; 2020; 121():237-251. PubMed ID: 32312423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantum Molecular Dynamics, Topological, Group Theoretical and Graph Theoretical Studies of Protein-Protein Interactions.
    Balasubramanian K; Gupta SP
    Curr Top Med Chem; 2019; 19(6):426-443. PubMed ID: 30836919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Protein Degradation and Regulation with Molecular Glue: Past and Recent Discoveries.
    Fang Y; He Q; Cao J
    Curr Med Chem; 2022; 29(14):2490-2503. PubMed ID: 34365941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical and computational fragment-based approaches to targeting protein-protein interactions: applications in structure-guided drug discovery.
    Winter A; Higueruelo AP; Marsh M; Sigurdardottir A; Pitt WR; Blundell TL
    Q Rev Biophys; 2012 Nov; 45(4):383-426. PubMed ID: 22971516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Druggable protein-protein interactions--from hot spots to hot segments.
    London N; Raveh B; Schueler-Furman O
    Curr Opin Chem Biol; 2013 Dec; 17(6):952-9. PubMed ID: 24183815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disruption of protein-protein interactions as a therapeutic strategy for prostate cancer.
    Matos B; Howl J; Jerónimo C; Fardilha M
    Pharmacol Res; 2020 Nov; 161():105145. PubMed ID: 32814172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovering protein-protein interaction stabilisers by native mass spectrometry.
    Bellamy-Carter J; Mohata M; Falcicchio M; Basran J; Higuchi Y; Doveston RG; Leney AC
    Chem Sci; 2021 Aug; 12(32):10724-10731. PubMed ID: 34447561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.